Carna Biosciences Inc
TSE:4572
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
JP |
Carna Biosciences Inc
TSE:4572
|
7.6B JPY | -2.8 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
221.8B USD | 29.1 | ||
US |
Danaher Corp
NYSE:DHR
|
184.8B USD | 27.9 | ||
US |
Agilent Technologies Inc
NYSE:A
|
41.8B USD | 21.8 | ||
CH |
Lonza Group AG
SIX:LONN
|
38B CHF | 27.9 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
56.3T KRW | 33.3 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.4B USD | 24.6 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
27B USD | 29.8 | ||
US |
West Pharmaceutical Services Inc
NYSE:WST
|
26.8B USD | 34.7 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
25.8B USD | 21.9 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
18.8B EUR | 33.3 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.